Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 5
2004 5
2005 1
2006 4
2007 3
2008 4
2009 3
2010 1
2011 1
2012 2
2013 2
2014 6
2015 6
2016 7
2017 3
2018 3
2019 6
2020 8
2021 5
2022 6
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Untargeted Metabolomic Profiling Reveals Differentially Expressed Serum Metabolites and Pathways in Type 2 Diabetes Patients with and without Cognitive Decline: A Cross-Sectional Study.
Al-Akl NS, Khalifa O, Ponirakis G, Parray A, Ramadan M, Khan S, Chandran M, Ayadathil R, Elsotouhy A, Own A, Al Hamad H, Decock J, Alajez NM, Albagha O, Malik RA, El-Agnaf OMA, Arredouani A. Al-Akl NS, et al. Among authors: el agnaf oma. Int J Mol Sci. 2024 Feb 13;25(4):2247. doi: 10.3390/ijms25042247. Int J Mol Sci. 2024. PMID: 38396924 Free PMC article.
Corrigendum to " Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy Body Disease" [Neurobiology of Disease127 (2019) 163-177].
Spencer B, Trinh I, Rockenstein E, Mante M, Florio J, Adame A, El-Agnaf OMA, Kim C, Masliah E, Rissman RA. Spencer B, et al. Among authors: el agnaf oma. Neurobiol Dis. 2024 Feb;191:106397. doi: 10.1016/j.nbd.2023.106397. Epub 2024 Jan 12. Neurobiol Dis. 2024. PMID: 38216383 Free article. No abstract available.
Profiling the autoantibody repertoire reveals autoantibodies associated with mild cognitive impairment and dementia.
Ehtewish H, Mesleh A, Ponirakis G, Lennard K, Al Hamad H, Chandran M, Parray A, Abdesselem H, Wijten P, Decock J, Alajez NM, Ramadan M, Khan S, Ayadathil R, Own A, Elsotouhy A, Albagha O, Arredouani A, Blackburn JM, Malik RA, El-Agnaf OMA. Ehtewish H, et al. Among authors: el agnaf oma. Front Neurol. 2023 Nov 30;14:1256745. doi: 10.3389/fneur.2023.1256745. eCollection 2023. Front Neurol. 2023. PMID: 38107644 Free PMC article.
High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder.
Mesleh A, Ehtewish H, Lennard K, Abdesselem HB, Al-Shaban F, Decock J, Alajez NM, Arredouani A, Emara MM, Albagha O, Stanton LW, Abdulla SA, Blackburnand JM, El-Agnaf OMA. Mesleh A, et al. Among authors: el agnaf oma. Front Mol Neurosci. 2023 Oct 16;16:1222506. doi: 10.3389/fnmol.2023.1222506. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37908488 Free PMC article.
Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia.
Ehtewish H, Mesleh A, Ponirakis G, De la Fuente A, Parray A, Bensmail I, Abdesselem H, Ramadan M, Khan S, Chandran M, Ayadathil R, Elsotouhy A, Own A, Al Hamad H, Abdelalim EM, Decock J, Alajez NM, Albagha O, Thornalley PJ, Arredouani A, Malik RA, El-Agnaf OMA. Ehtewish H, et al. Among authors: el agnaf oma. Int J Mol Sci. 2023 May 1;24(9):8117. doi: 10.3390/ijms24098117. Int J Mol Sci. 2023. PMID: 37175824 Free PMC article.
Blood Proteomics Analysis Reveals Potential Biomarkers and Convergent Dysregulated Pathways in Autism Spectrum Disorder: A Pilot Study.
Mesleh A, Ehtewish H, de la Fuente A, Al-Shamari H, Ghazal I, Al-Faraj F, Al-Shaban F, Abdesselem HB, Emara M, Alajez NM, Arredouani A, Decock J, Albagha O, Stanton LW, Abdulla SA, El-Agnaf OMA. Mesleh A, et al. Among authors: el agnaf oma. Int J Mol Sci. 2023 Apr 18;24(8):7443. doi: 10.3390/ijms24087443. Int J Mol Sci. 2023. PMID: 37108604 Free PMC article.
Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson's disease.
Nim S, O'Hara DM, Corbi-Verge C, Perez-Riba A, Fujisawa K, Kapadia M, Chau H, Albanese F, Pawar G, De Snoo ML, Ngana SG, Kim J, El-Agnaf OMA, Rennella E, Kay LE, Kalia SK, Kalia LV, Kim PM. Nim S, et al. Among authors: el agnaf oma. Nat Commun. 2023 Apr 19;14(1):2150. doi: 10.1038/s41467-023-37464-2. Nat Commun. 2023. PMID: 37076542 Free PMC article.
89 results